Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2014

01-08-2014 | Research Article

A national drug related problems database: evaluation of use in practice, reliability and reproducibility

Authors: Lene Juel Kjeldsen, Trine Birkholm, Hanne Fischer, Trine Graabæk, Merete Kjær Hansen, Karina Porsborg Kibsdal, Lene Vestergaard Ravn-Nielsen, Tania Holtum Truelshøj

Published in: International Journal of Clinical Pharmacy | Issue 4/2014

Login to get access

Abstract

Background A drug related problems database (DRP-database) was developed on request by clinical pharmacists. The information from the DRP-database has only been used locally e.g. to identify focus areas and to communicate identified DRPs to the hospital wards. Hence the quality of the data at the national level is unknown, which may compromise national analyses for benchmarking and identification of national focus areas. Objective The aim of the study was to evaluate the use in practice, reliability and reproducibility of the DRPs documented in the Danish drug related problems database. Setting Danish hospital pharmacies. Methods Practice use of the DRP-database was explored by an electronic questionnaire distributed to hospital pharmacies, and consisted of questions regarding current and previous use of the DRP-database. The reliability was evaluated by comparing the categorization of 24 cases by clinical pharmacists with categorization performed by the project group. Reproducibility was explored by re-categorization of a sample of existing records in the DRP-database by two project group members individually. Main outcome measures Observed proportion of agreement and Fleiss’ kappa as measures of inter-rater reliability and reproducibility. Results The practice use study of 12 hospital pharmacy locations revealed that when implementing the DRP-database, the majority of identified DRPs are documented in the DRP-database, however, some variations throughout the country exist. The interrater reliability study of 34 clinical pharmacists showed high inter-rater reliability with the project group (Fleiss’ kappa = 0.79 with 95 % CI (0.70; 0.88)), and the reproducibility study also documented high inter-rater reliability of a sample of 379 records from the DRP-database re-categorized by two project group members (Fleiss’ kappa = 0.81 with 95 % CI (0.78; 0.85)). Conclusion The study showed high reliability and reproducibility of the DRP-database, however, some local variation in the use of the DRP-database throughout the country existed affecting the overall quality. These findings indicate that data in the DRP-database may be pooled, and national analyses may be conducted to explore development areas for common interest.
Appendix
Available only for authorised users
Literature
1.
go back to reference van den Bemt PM, Egberts TC, van den de Jong Berg LT, Brouwers JR. Drug-related problems in hospitalised patients. Drug Saf. 2000;22(4):321–33.PubMedCrossRef van den Bemt PM, Egberts TC, van den de Jong Berg LT, Brouwers JR. Drug-related problems in hospitalised patients. Drug Saf. 2000;22(4):321–33.PubMedCrossRef
2.
go back to reference Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30(5):379–407.PubMedCrossRef Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30(5):379–407.PubMedCrossRef
3.
go back to reference Graabaek T, Kjeldsen LJ. Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic Clin Pharmacol Toxicol. 2013;112(6):359–73.PubMedCrossRef Graabaek T, Kjeldsen LJ. Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic Clin Pharmacol Toxicol. 2013;112(6):359–73.PubMedCrossRef
4.
go back to reference Van Mil F, Westerlund T, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859–67.PubMedCrossRef Van Mil F, Westerlund T, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38:859–67.PubMedCrossRef
5.
go back to reference Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed
6.
go back to reference Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045–51.PubMedCrossRef Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045–51.PubMedCrossRef
7.
go back to reference ASHP guidelines on a standardized method for pharmaceutical care. In: Deffenbaugh J, editor. Best practices for health-system pharmacy. Bethesda, MD: American Society of Health-System Pharmacists, 1996. pp. 109–11. ASHP guidelines on a standardized method for pharmaceutical care. In: Deffenbaugh J, editor. Best practices for health-system pharmacy. Bethesda, MD: American Society of Health-System Pharmacists, 1996. pp. 109–11.
10.
go back to reference Fleiss J. Measuring nominal scale agreement among many raters. Psychol Bull. 1971;76(5):378–82.CrossRef Fleiss J. Measuring nominal scale agreement among many raters. Psychol Bull. 1971;76(5):378–82.CrossRef
12.
go back to reference Canty A, Ripley B. Boot: bootstrap R (S-Plus) functions. R package version 1.3-9, 2013. Canty A, Ripley B. Boot: bootstrap R (S-Plus) functions. R package version 1.3-9, 2013.
13.
go back to reference Efron B. Better bootstrap confidence intervals. J Am Stat Assoc. 1987;82(397):171–85.CrossRef Efron B. Better bootstrap confidence intervals. J Am Stat Assoc. 1987;82(397):171–85.CrossRef
14.
go back to reference Hall P. Theoretical comparison of bootstrap confidence intervals. Ann Stat. 1988;16(3):927–53.CrossRef Hall P. Theoretical comparison of bootstrap confidence intervals. Ann Stat. 1988;16(3):927–53.CrossRef
15.
go back to reference Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85:257–68.PubMed Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85:257–68.PubMed
16.
go back to reference Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.PubMedCrossRef Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.PubMedCrossRef
17.
go back to reference R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria [internet]; 2013 [updated 2013 Sep 25; cited 2014 Feb 14]. Available from: http://www.R-project.org/. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria [internet]; 2013 [updated 2013 Sep 25; cited 2014 Feb 14]. Available from: http://​www.​R-project.​org/​.
18.
go back to reference Nielsen TR, Andersen SE, Rasmussen M, Honoré PH. Clinical pharmacist service in the acute ward. Int J Clin Pharm. 2013;35(6):1137–51.PubMedCrossRef Nielsen TR, Andersen SE, Rasmussen M, Honoré PH. Clinical pharmacist service in the acute ward. Int J Clin Pharm. 2013;35(6):1137–51.PubMedCrossRef
19.
go back to reference Hohmann C, Eickhoff C, Klotz JM, Schulz M, Radziwill R. Development of a classification system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability. J Clin Pharm Ther. 2012;37(3):276–81.PubMedCrossRef Hohmann C, Eickhoff C, Klotz JM, Schulz M, Radziwill R. Development of a classification system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability. J Clin Pharm Ther. 2012;37(3):276–81.PubMedCrossRef
20.
go back to reference Allenet B, Bedouch P, Rose FX, Escofier L, Roubille R, Charpiat B, Juste M, Conort O. Validation of an instrument for the documentation of clinical pharmacists’ interventions. Pharm World Sci. 2006;28(4):181–8.PubMedCrossRef Allenet B, Bedouch P, Rose FX, Escofier L, Roubille R, Charpiat B, Juste M, Conort O. Validation of an instrument for the documentation of clinical pharmacists’ interventions. Pharm World Sci. 2006;28(4):181–8.PubMedCrossRef
21.
go back to reference Somers A, Mallet L, van der Cammen T, Robays H, Petrovic M. Applicability of an adapted medication appropriateness index for detection of drug-related problems in geriatric inpatients. Am J Geriatr Pharmacother. 2012;10(2):101–9.PubMedCrossRef Somers A, Mallet L, van der Cammen T, Robays H, Petrovic M. Applicability of an adapted medication appropriateness index for detection of drug-related problems in geriatric inpatients. Am J Geriatr Pharmacother. 2012;10(2):101–9.PubMedCrossRef
22.
go back to reference Hoth AB, Carter BL, Ness J, Bhattacharyya A, Shorr RI, Rosenthal GE, Kaboli PJ. Development and reliability testing of the clinical pharmacist recommendation taxonomy. Pharmacotherapy. 2007;27(5):639–46.PubMedCrossRef Hoth AB, Carter BL, Ness J, Bhattacharyya A, Shorr RI, Rosenthal GE, Kaboli PJ. Development and reliability testing of the clinical pharmacist recommendation taxonomy. Pharmacotherapy. 2007;27(5):639–46.PubMedCrossRef
23.
go back to reference Sorensen L, Grobler MP, Roberts MS. Development of a quality use of medicines coding system to rate clinical pharmacists’ medication review recommendations. Pharm World Sci. 2003;25(5):212–7.PubMedCrossRef Sorensen L, Grobler MP, Roberts MS. Development of a quality use of medicines coding system to rate clinical pharmacists’ medication review recommendations. Pharm World Sci. 2003;25(5):212–7.PubMedCrossRef
24.
go back to reference Somers A, Robays H, De Paepe P, Van Maele G, Perehudoff K, Petrovic M. Evaluation of clinical pharmacist recommendations in the geriatric ward of a Belgian university hospital. Clin Interv Aging. 2013;8:703–9.PubMedCentralPubMedCrossRef Somers A, Robays H, De Paepe P, Van Maele G, Perehudoff K, Petrovic M. Evaluation of clinical pharmacist recommendations in the geriatric ward of a Belgian university hospital. Clin Interv Aging. 2013;8:703–9.PubMedCentralPubMedCrossRef
Metadata
Title
A national drug related problems database: evaluation of use in practice, reliability and reproducibility
Authors
Lene Juel Kjeldsen
Trine Birkholm
Hanne Fischer
Trine Graabæk
Merete Kjær Hansen
Karina Porsborg Kibsdal
Lene Vestergaard Ravn-Nielsen
Tania Holtum Truelshøj
Publication date
01-08-2014
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 4/2014
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-014-9957-2

Other articles of this Issue 4/2014

International Journal of Clinical Pharmacy 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.